Five-year survival in 432 cirrhotic patients with hepatocellular carcinoma (HCC) ≤4cm treated with us-guided percutaneous laser ablation (PLA): A multicentric study
CM Pacella, G Francica, G Bizzarri, V Arienti, F Magnolfi, FML Di Lascio, B Caspani, S Pretolani, E Antico, R Regine, A Salomone Megna, M Sponza · Ultraschall in der Medizin - European Journal of Ultrasound · 2007 · Heft 10
Bibliografische Angaben
Zusammenfassung
Purpose: to analyze outcome predictors in cirrhotic patients with HCC tumors enrolled in a multicentric study and treated with PLA. Methods: this retrospective study included 432 consecutive patients with Child's Class A (58.6%) or B cirrhosis (males 64.4%; HCV+ 68%; mean age 67.7yrs)and 548 HCC nodules ≤4cm (mean diameter 25.6mm). During a 12-year period, all patients underwent US-guided PLA at nine centres where a multiple fibre (up to 4) technique and a Nd:YAG laser operating at a wavelength of 1,064 nm were used. Predictors of survival were identified through logistic regression. Probability curves obtained…